123 related articles for article (PubMed ID: 2138351)
1. [Current aspects and trends in immunotherapy of cancer].
Boniver J; Schaaf-Lafontaine N; Moutschen M; Longrée L; Lovens-Degraef D; Fassotte MF; Reginster MA; Simonet-Martin MT; Baudrihaye M
Rev Med Liege; 1990 Feb; 45(2):41-8. PubMed ID: 2138351
[No Abstract] [Full Text] [Related]
2. Lymphokine-activated killer cells/tumor-infiltrating lymphocytes therapy: efficacy, toxicity, controversies.
Dutcher JP
J Clin Apher; 1990; 5(2):80-2. PubMed ID: 2404970
[No Abstract] [Full Text] [Related]
3. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
4. [New era of tumor immunotherapy].
Yoshitake Y; Nakatsura T; Nishimura Y
Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
[No Abstract] [Full Text] [Related]
5. Helper and cytotoxic lymphocyte responses to chronic myeloid leukaemia: implications for adoptive immunotherapy with T cells.
Lewalle P; Hensel N; Guimaraes A; Couriel D; Jiang Y Z; Mavroudis D; Barrett AJ
Br J Haematol; 1996 Mar; 92(3):587-94. PubMed ID: 8616022
[TBL] [Abstract][Full Text] [Related]
6. Postoperative immunosuppression cascade and immunotherapy using lymphokine-activated killer cells for patients with esophageal cancer: possible application for compensatory anti-inflammatory response syndrome.
Yamaguchi Y; Hihara J; Hironaka K; Ohshita A; Okita R; Okawaki M; Matsuura K; Nagamine I; Ikeda T; Ohara M; Hamai Y
Oncol Rep; 2006 Apr; 15(4):895-901. PubMed ID: 16525677
[TBL] [Abstract][Full Text] [Related]
7. Recombinant antibody fusion proteins for cancer immunotherapy.
Reisfeld RA; Gillies SD
Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():27-53. PubMed ID: 8815009
[No Abstract] [Full Text] [Related]
8. [Our experience with lymphocytes activated against cancer: CTL cells].
Marcellino LR; Vinciguerra M; Marcellino MV; Sessa E
G Chir; 1997 Oct; 18(10):605-7. PubMed ID: 9479972
[TBL] [Abstract][Full Text] [Related]
9. Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.
Yoshino I; Yano T; Murata M; Ishida T; Sugimachi K; Kimura G; Nomoto K
Cancer Res; 1991 Mar; 51(5):1494-8. PubMed ID: 1997188
[TBL] [Abstract][Full Text] [Related]
10. Role of human circulating and tumor-infiltrating lymphocytes in cancer defense and treatment.
Lotzová E
Nat Immun Cell Growth Regul; 1990; 9(4):253-64. PubMed ID: 2215514
[TBL] [Abstract][Full Text] [Related]
11. Increased lysis of melanoma by in vivo-elicited human lymphokine-activated killer cells after addition of antiganglioside antibodies in vitro.
Harel W; Shau H; Hadley CG; Morgan AC; Reisfeld RA; Cheresh DA; Mitchell MS
Cancer Res; 1990 Oct; 50(19):6311-5. PubMed ID: 2400994
[TBL] [Abstract][Full Text] [Related]
12. Induction and expansion of LAK cells for cancer immunotherapy.
Hamblin TJ
Prog Clin Biol Res; 1990; 337():551-3. PubMed ID: 2353017
[No Abstract] [Full Text] [Related]
13. [Immunotherapy for malignant glioblastoma].
Nose T; Nakagawa K
No Shinkei Geka; 1995 Mar; 23(3):195-206. PubMed ID: 7700486
[No Abstract] [Full Text] [Related]
14. Adoptive immunotherapy.
Sznol M; Urba WJ
Cancer Chemother Biol Response Modif; 1994; 15():213-25. PubMed ID: 7779587
[No Abstract] [Full Text] [Related]
15. The role of T lymphocytes in the immunotherapy of tumours.
Brondz BD; Balashov KE
Biomed Sci; 1991; 2(5):441-9. PubMed ID: 1840832
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine activated killer cells: a new approach to immunotherapy of cancer.
Semenzato G
Leukemia; 1990 Feb; 4(2):71-80. PubMed ID: 2406518
[No Abstract] [Full Text] [Related]
17. Approaches to immunotherapy of cancer: characterization of lymphokines as second signals for cytotoxic T-cell generation.
Bertagnolli MM; Herrmann SH; Pinto VM; Schoof DD; Eberlein TJ
Surgery; 1991 Sep; 110(3):459-68. PubMed ID: 1887370
[TBL] [Abstract][Full Text] [Related]
18. In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors.
Rivoltini L; Gambacorti-Passerini C; Squadrelli-Saraceno M; Grosso MI; Cantù G; Molinari R; Orazi A; Parmiani G
Cancer Res; 1990 Sep; 50(17):5551-7. PubMed ID: 2386961
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes].
Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Inoue M; Tamai M
Nihon Gan Chiryo Gakkai Shi; 1990 May; 25(5):978-89. PubMed ID: 2391445
[TBL] [Abstract][Full Text] [Related]
20. Adoptive cellular therapy.
Sznol M; Urba WJ
Cancer Chemother Biol Response Modif; 1992; 13():191-204. PubMed ID: 1389910
[No Abstract] [Full Text] [Related]
[Next] [New Search]